ClinicalTrials.govpublic full text
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.
prostate cancer, prostate adenocarcinoma, prostate neoplasm, prostate cancer metastatic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801725
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.